Global L-Dopa Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global L-Dopa Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 25 Aug 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global L-Dopa market size was valued at USD 470.2 million in 2022 and is forecast to a readjusted size of USD 1327.5 million by 2029 with a CAGR of 16.0% during review period.

L-Dopa is the prodrug of dopamine (DA), which has no pharmacological activity itself, enters the center through the blood-brain barrier, and is converted into DA by the action of dopa decarboxylase to exert pharmacological effects.

L-Dopa, also known as levodopa, is a medication used primarily to treat Parkinson's disease and dopamine-responsive dystonia. The L-Dopa market is driven by several factors that reflect the growing prevalence of Parkinson's disease and the continuous advancements in medical treatment. Here are some key drivers that contribute to the L-Dopa market:
Prevalence of Parkinson's Disease: Parkinson's disease is a neurodegenerative disorder that affects a significant portion of the aging population. As the global population ages, the incidence and prevalence of Parkinson's disease increase, driving the demand for effective treatments like L-Dopa.

Clinical Efficacy: L-Dopa is considered one of the most effective medications for managing the motor symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia. Its ability to improve patients' quality of life and functional capacity is a major driver of its demand.

Mainstay Treatment: L-Dopa is often used as a foundational or mainstay treatment for Parkinson's disease. It can provide substantial relief from symptoms, allowing patients to maintain better daily functioning.

Combination Therapies: L-Dopa is often combined with other medications, such as dopamine agonists, to optimize symptom control and manage the disease over the long term. This approach contributes to its continued demand.

Continuous Research and Development: The medical community continues to explore and develop new formulations and delivery methods for L-Dopa to enhance its effectiveness, reduce side effects, and improve patient compliance.

The Global Info Research report includes an overview of the development of the L-Dopa industry chain, the market status of Parkinson Disease Medicine (Purity: 98%, Purity: 99%), Hepatic Encephalopathy Medicine (Purity: 98%, Purity: 99%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of L-Dopa.

Regionally, the report analyzes the L-Dopa markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global L-Dopa market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the L-Dopa market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the L-Dopa industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Purity: 98%, Purity: 99%).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the L-Dopa market.

Regional Analysis: The report involves examining the L-Dopa market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the L-Dopa market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to L-Dopa:
Company Analysis: Report covers individual L-Dopa manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards L-Dopa This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Parkinson Disease Medicine, Hepatic Encephalopathy Medicine).

Technology Analysis: Report covers specific technologies relevant to L-Dopa. It assesses the current state, advancements, and potential future developments in L-Dopa areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the L-Dopa market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
L-Dopa market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Purity: 98%
Purity: 99%

Market segment by Application
Parkinson Disease Medicine
Hepatic Encephalopathy Medicine
Others

Major players covered
Ajinomoto
Daiichi Sankyo
Divis Laboratories
Tiefenbacher API + Ingredients
Teva Pharmaceutical Industries
Xinhua Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Wild Wind Pharmaceutical
JL Pharm
ChenLv Herb

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe L-Dopa product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of L-Dopa, with price, sales, revenue and global market share of L-Dopa from 2018 to 2023.
Chapter 3, the L-Dopa competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the L-Dopa breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and L-Dopa market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of L-Dopa.
Chapter 14 and 15, to describe L-Dopa sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of L-Dopa
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global L-Dopa Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity: 98%
1.3.3 Purity: 99%
1.4 Market Analysis by Application
1.4.1 Overview: Global L-Dopa Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Parkinson Disease Medicine
1.4.3 Hepatic Encephalopathy Medicine
1.4.4 Others
1.5 Global L-Dopa Market Size & Forecast
1.5.1 Global L-Dopa Consumption Value (2018 & 2022 & 2029)
1.5.2 Global L-Dopa Sales Quantity (2018-2029)
1.5.3 Global L-Dopa Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Ajinomoto
2.1.1 Ajinomoto Details
2.1.2 Ajinomoto Major Business
2.1.3 Ajinomoto L-Dopa Product and Services
2.1.4 Ajinomoto L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Ajinomoto Recent Developments/Updates
2.2 Daiichi Sankyo
2.2.1 Daiichi Sankyo Details
2.2.2 Daiichi Sankyo Major Business
2.2.3 Daiichi Sankyo L-Dopa Product and Services
2.2.4 Daiichi Sankyo L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Daiichi Sankyo Recent Developments/Updates
2.3 Divis Laboratories
2.3.1 Divis Laboratories Details
2.3.2 Divis Laboratories Major Business
2.3.3 Divis Laboratories L-Dopa Product and Services
2.3.4 Divis Laboratories L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Divis Laboratories Recent Developments/Updates
2.4 Tiefenbacher API + Ingredients
2.4.1 Tiefenbacher API + Ingredients Details
2.4.2 Tiefenbacher API + Ingredients Major Business
2.4.3 Tiefenbacher API + Ingredients L-Dopa Product and Services
2.4.4 Tiefenbacher API + Ingredients L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tiefenbacher API + Ingredients Recent Developments/Updates
2.5 Teva Pharmaceutical Industries
2.5.1 Teva Pharmaceutical Industries Details
2.5.2 Teva Pharmaceutical Industries Major Business
2.5.3 Teva Pharmaceutical Industries L-Dopa Product and Services
2.5.4 Teva Pharmaceutical Industries L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.6 Xinhua Pharmaceutical
2.6.1 Xinhua Pharmaceutical Details
2.6.2 Xinhua Pharmaceutical Major Business
2.6.3 Xinhua Pharmaceutical L-Dopa Product and Services
2.6.4 Xinhua Pharmaceutical L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Xinhua Pharmaceutical Recent Developments/Updates
2.7 Zhejiang Huahai Pharmaceutical
2.7.1 Zhejiang Huahai Pharmaceutical Details
2.7.2 Zhejiang Huahai Pharmaceutical Major Business
2.7.3 Zhejiang Huahai Pharmaceutical L-Dopa Product and Services
2.7.4 Zhejiang Huahai Pharmaceutical L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
2.8 Zhejiang Wild Wind Pharmaceutical
2.8.1 Zhejiang Wild Wind Pharmaceutical Details
2.8.2 Zhejiang Wild Wind Pharmaceutical Major Business
2.8.3 Zhejiang Wild Wind Pharmaceutical L-Dopa Product and Services
2.8.4 Zhejiang Wild Wind Pharmaceutical L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
2.9 JL Pharm
2.9.1 JL Pharm Details
2.9.2 JL Pharm Major Business
2.9.3 JL Pharm L-Dopa Product and Services
2.9.4 JL Pharm L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 JL Pharm Recent Developments/Updates
2.10 ChenLv Herb
2.10.1 ChenLv Herb Details
2.10.2 ChenLv Herb Major Business
2.10.3 ChenLv Herb L-Dopa Product and Services
2.10.4 ChenLv Herb L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ChenLv Herb Recent Developments/Updates

3 Competitive Environment: L-Dopa by Manufacturer
3.1 Global L-Dopa Sales Quantity by Manufacturer (2018-2023)
3.2 Global L-Dopa Revenue by Manufacturer (2018-2023)
3.3 Global L-Dopa Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of L-Dopa by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 L-Dopa Manufacturer Market Share in 2022
3.4.2 Top 6 L-Dopa Manufacturer Market Share in 2022
3.5 L-Dopa Market: Overall Company Footprint Analysis
3.5.1 L-Dopa Market: Region Footprint
3.5.2 L-Dopa Market: Company Product Type Footprint
3.5.3 L-Dopa Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global L-Dopa Market Size by Region
4.1.1 Global L-Dopa Sales Quantity by Region (2018-2029)
4.1.2 Global L-Dopa Consumption Value by Region (2018-2029)
4.1.3 Global L-Dopa Average Price by Region (2018-2029)
4.2 North America L-Dopa Consumption Value (2018-2029)
4.3 Europe L-Dopa Consumption Value (2018-2029)
4.4 Asia-Pacific L-Dopa Consumption Value (2018-2029)
4.5 South America L-Dopa Consumption Value (2018-2029)
4.6 Middle East and Africa L-Dopa Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global L-Dopa Sales Quantity by Type (2018-2029)
5.2 Global L-Dopa Consumption Value by Type (2018-2029)
5.3 Global L-Dopa Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global L-Dopa Sales Quantity by Application (2018-2029)
6.2 Global L-Dopa Consumption Value by Application (2018-2029)
6.3 Global L-Dopa Average Price by Application (2018-2029)

7 North America
7.1 North America L-Dopa Sales Quantity by Type (2018-2029)
7.2 North America L-Dopa Sales Quantity by Application (2018-2029)
7.3 North America L-Dopa Market Size by Country
7.3.1 North America L-Dopa Sales Quantity by Country (2018-2029)
7.3.2 North America L-Dopa Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe L-Dopa Sales Quantity by Type (2018-2029)
8.2 Europe L-Dopa Sales Quantity by Application (2018-2029)
8.3 Europe L-Dopa Market Size by Country
8.3.1 Europe L-Dopa Sales Quantity by Country (2018-2029)
8.3.2 Europe L-Dopa Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific L-Dopa Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific L-Dopa Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific L-Dopa Market Size by Region
9.3.1 Asia-Pacific L-Dopa Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific L-Dopa Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America L-Dopa Sales Quantity by Type (2018-2029)
10.2 South America L-Dopa Sales Quantity by Application (2018-2029)
10.3 South America L-Dopa Market Size by Country
10.3.1 South America L-Dopa Sales Quantity by Country (2018-2029)
10.3.2 South America L-Dopa Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa L-Dopa Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa L-Dopa Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa L-Dopa Market Size by Country
11.3.1 Middle East & Africa L-Dopa Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa L-Dopa Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 L-Dopa Market Drivers
12.2 L-Dopa Market Restraints
12.3 L-Dopa Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of L-Dopa and Key Manufacturers
13.2 Manufacturing Costs Percentage of L-Dopa
13.3 L-Dopa Production Process
13.4 L-Dopa Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 L-Dopa Typical Distributors
14.3 L-Dopa Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global L-Dopa Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global L-Dopa Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Ajinomoto Basic Information, Manufacturing Base and Competitors
Table 4. Ajinomoto Major Business
Table 5. Ajinomoto L-Dopa Product and Services
Table 6. Ajinomoto L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Ajinomoto Recent Developments/Updates
Table 8. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 9. Daiichi Sankyo Major Business
Table 10. Daiichi Sankyo L-Dopa Product and Services
Table 11. Daiichi Sankyo L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Daiichi Sankyo Recent Developments/Updates
Table 13. Divis Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Divis Laboratories Major Business
Table 15. Divis Laboratories L-Dopa Product and Services
Table 16. Divis Laboratories L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Divis Laboratories Recent Developments/Updates
Table 18. Tiefenbacher API + Ingredients Basic Information, Manufacturing Base and Competitors
Table 19. Tiefenbacher API + Ingredients Major Business
Table 20. Tiefenbacher API + Ingredients L-Dopa Product and Services
Table 21. Tiefenbacher API + Ingredients L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tiefenbacher API + Ingredients Recent Developments/Updates
Table 23. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Major Business
Table 25. Teva Pharmaceutical Industries L-Dopa Product and Services
Table 26. Teva Pharmaceutical Industries L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teva Pharmaceutical Industries Recent Developments/Updates
Table 28. Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Xinhua Pharmaceutical Major Business
Table 30. Xinhua Pharmaceutical L-Dopa Product and Services
Table 31. Xinhua Pharmaceutical L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Xinhua Pharmaceutical Recent Developments/Updates
Table 33. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Zhejiang Huahai Pharmaceutical Major Business
Table 35. Zhejiang Huahai Pharmaceutical L-Dopa Product and Services
Table 36. Zhejiang Huahai Pharmaceutical L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 38. Zhejiang Wild Wind Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Zhejiang Wild Wind Pharmaceutical Major Business
Table 40. Zhejiang Wild Wind Pharmaceutical L-Dopa Product and Services
Table 41. Zhejiang Wild Wind Pharmaceutical L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
Table 43. JL Pharm Basic Information, Manufacturing Base and Competitors
Table 44. JL Pharm Major Business
Table 45. JL Pharm L-Dopa Product and Services
Table 46. JL Pharm L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. JL Pharm Recent Developments/Updates
Table 48. ChenLv Herb Basic Information, Manufacturing Base and Competitors
Table 49. ChenLv Herb Major Business
Table 50. ChenLv Herb L-Dopa Product and Services
Table 51. ChenLv Herb L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. ChenLv Herb Recent Developments/Updates
Table 53. Global L-Dopa Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 54. Global L-Dopa Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global L-Dopa Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 56. Market Position of Manufacturers in L-Dopa, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and L-Dopa Production Site of Key Manufacturer
Table 58. L-Dopa Market: Company Product Type Footprint
Table 59. L-Dopa Market: Company Product Application Footprint
Table 60. L-Dopa New Market Entrants and Barriers to Market Entry
Table 61. L-Dopa Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global L-Dopa Sales Quantity by Region (2018-2023) & (Tons)
Table 63. Global L-Dopa Sales Quantity by Region (2024-2029) & (Tons)
Table 64. Global L-Dopa Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global L-Dopa Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global L-Dopa Average Price by Region (2018-2023) & (US$/Ton)
Table 67. Global L-Dopa Average Price by Region (2024-2029) & (US$/Ton)
Table 68. Global L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 69. Global L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 70. Global L-Dopa Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global L-Dopa Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global L-Dopa Average Price by Type (2018-2023) & (US$/Ton)
Table 73. Global L-Dopa Average Price by Type (2024-2029) & (US$/Ton)
Table 74. Global L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 75. Global L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 76. Global L-Dopa Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global L-Dopa Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global L-Dopa Average Price by Application (2018-2023) & (US$/Ton)
Table 79. Global L-Dopa Average Price by Application (2024-2029) & (US$/Ton)
Table 80. North America L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 81. North America L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 82. North America L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 83. North America L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 84. North America L-Dopa Sales Quantity by Country (2018-2023) & (Tons)
Table 85. North America L-Dopa Sales Quantity by Country (2024-2029) & (Tons)
Table 86. North America L-Dopa Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America L-Dopa Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 89. Europe L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 90. Europe L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 91. Europe L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 92. Europe L-Dopa Sales Quantity by Country (2018-2023) & (Tons)
Table 93. Europe L-Dopa Sales Quantity by Country (2024-2029) & (Tons)
Table 94. Europe L-Dopa Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe L-Dopa Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 97. Asia-Pacific L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 98. Asia-Pacific L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 99. Asia-Pacific L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 100. Asia-Pacific L-Dopa Sales Quantity by Region (2018-2023) & (Tons)
Table 101. Asia-Pacific L-Dopa Sales Quantity by Region (2024-2029) & (Tons)
Table 102. Asia-Pacific L-Dopa Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific L-Dopa Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 105. South America L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 106. South America L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 107. South America L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 108. South America L-Dopa Sales Quantity by Country (2018-2023) & (Tons)
Table 109. South America L-Dopa Sales Quantity by Country (2024-2029) & (Tons)
Table 110. South America L-Dopa Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America L-Dopa Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 113. Middle East & Africa L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 114. Middle East & Africa L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 115. Middle East & Africa L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 116. Middle East & Africa L-Dopa Sales Quantity by Region (2018-2023) & (Tons)
Table 117. Middle East & Africa L-Dopa Sales Quantity by Region (2024-2029) & (Tons)
Table 118. Middle East & Africa L-Dopa Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa L-Dopa Consumption Value by Region (2024-2029) & (USD Million)
Table 120. L-Dopa Raw Material
Table 121. Key Manufacturers of L-Dopa Raw Materials
Table 122. L-Dopa Typical Distributors
Table 123. L-Dopa Typical Customers
List of Figures
Figure 1. L-Dopa Picture
Figure 2. Global L-Dopa Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global L-Dopa Consumption Value Market Share by Type in 2022
Figure 4. Purity: 98% Examples
Figure 5. Purity: 99% Examples
Figure 6. Global L-Dopa Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global L-Dopa Consumption Value Market Share by Application in 2022
Figure 8. Parkinson Disease Medicine Examples
Figure 9. Hepatic Encephalopathy Medicine Examples
Figure 10. Others Examples
Figure 11. Global L-Dopa Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global L-Dopa Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global L-Dopa Sales Quantity (2018-2029) & (Tons)
Figure 14. Global L-Dopa Average Price (2018-2029) & (US$/Ton)
Figure 15. Global L-Dopa Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global L-Dopa Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of L-Dopa by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 L-Dopa Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 L-Dopa Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global L-Dopa Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global L-Dopa Consumption Value Market Share by Region (2018-2029)
Figure 22. North America L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 25. South America L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 27. Global L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global L-Dopa Consumption Value Market Share by Type (2018-2029)
Figure 29. Global L-Dopa Average Price by Type (2018-2029) & (US$/Ton)
Figure 30. Global L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global L-Dopa Consumption Value Market Share by Application (2018-2029)
Figure 32. Global L-Dopa Average Price by Application (2018-2029) & (US$/Ton)
Figure 33. North America L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America L-Dopa Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America L-Dopa Consumption Value Market Share by Country (2018-2029)
Figure 37. United States L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe L-Dopa Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe L-Dopa Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific L-Dopa Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific L-Dopa Consumption Value Market Share by Region (2018-2029)
Figure 53. China L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America L-Dopa Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America L-Dopa Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa L-Dopa Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa L-Dopa Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. L-Dopa Market Drivers
Figure 74. L-Dopa Market Restraints
Figure 75. L-Dopa Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of L-Dopa in 2022
Figure 78. Manufacturing Process Analysis of L-Dopa
Figure 79. L-Dopa Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Ajinomoto
Daiichi Sankyo
Divis Laboratories
Tiefenbacher API + Ingredients
Teva Pharmaceutical Industries
Xinhua Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Wild Wind Pharmaceutical
JL Pharm
ChenLv Herb
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global L-Dopa Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global L-Dopa Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 25 Aug 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global L-Dopa market size was valued at USD 470.2 million in 2022 and is forecast to a readjusted size of USD 1327.5 million by 2029 with a CAGR of 16.0% during review period.

L-Dopa is the prodrug of dopamine (DA), which has no pharmacological activity itself, enters the center through the blood-brain barrier, and is converted into DA by the action of dopa decarboxylase to exert pharmacological effects.

L-Dopa, also known as levodopa, is a medication used primarily to treat Parkinson's disease and dopamine-responsive dystonia. The L-Dopa market is driven by several factors that reflect the growing prevalence of Parkinson's disease and the continuous advancements in medical treatment. Here are some key drivers that contribute to the L-Dopa market:
Prevalence of Parkinson's Disease: Parkinson's disease is a neurodegenerative disorder that affects a significant portion of the aging population. As the global population ages, the incidence and prevalence of Parkinson's disease increase, driving the demand for effective treatments like L-Dopa.

Clinical Efficacy: L-Dopa is considered one of the most effective medications for managing the motor symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia. Its ability to improve patients' quality of life and functional capacity is a major driver of its demand.

Mainstay Treatment: L-Dopa is often used as a foundational or mainstay treatment for Parkinson's disease. It can provide substantial relief from symptoms, allowing patients to maintain better daily functioning.

Combination Therapies: L-Dopa is often combined with other medications, such as dopamine agonists, to optimize symptom control and manage the disease over the long term. This approach contributes to its continued demand.

Continuous Research and Development: The medical community continues to explore and develop new formulations and delivery methods for L-Dopa to enhance its effectiveness, reduce side effects, and improve patient compliance.

The Global Info Research report includes an overview of the development of the L-Dopa industry chain, the market status of Parkinson Disease Medicine (Purity: 98%, Purity: 99%), Hepatic Encephalopathy Medicine (Purity: 98%, Purity: 99%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of L-Dopa.

Regionally, the report analyzes the L-Dopa markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global L-Dopa market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the L-Dopa market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the L-Dopa industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Purity: 98%, Purity: 99%).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the L-Dopa market.

Regional Analysis: The report involves examining the L-Dopa market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the L-Dopa market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to L-Dopa:
Company Analysis: Report covers individual L-Dopa manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards L-Dopa This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Parkinson Disease Medicine, Hepatic Encephalopathy Medicine).

Technology Analysis: Report covers specific technologies relevant to L-Dopa. It assesses the current state, advancements, and potential future developments in L-Dopa areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the L-Dopa market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
L-Dopa market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Purity: 98%
Purity: 99%

Market segment by Application
Parkinson Disease Medicine
Hepatic Encephalopathy Medicine
Others

Major players covered
Ajinomoto
Daiichi Sankyo
Divis Laboratories
Tiefenbacher API + Ingredients
Teva Pharmaceutical Industries
Xinhua Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Wild Wind Pharmaceutical
JL Pharm
ChenLv Herb

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe L-Dopa product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of L-Dopa, with price, sales, revenue and global market share of L-Dopa from 2018 to 2023.
Chapter 3, the L-Dopa competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the L-Dopa breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and L-Dopa market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of L-Dopa.
Chapter 14 and 15, to describe L-Dopa sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of L-Dopa
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global L-Dopa Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity: 98%
1.3.3 Purity: 99%
1.4 Market Analysis by Application
1.4.1 Overview: Global L-Dopa Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Parkinson Disease Medicine
1.4.3 Hepatic Encephalopathy Medicine
1.4.4 Others
1.5 Global L-Dopa Market Size & Forecast
1.5.1 Global L-Dopa Consumption Value (2018 & 2022 & 2029)
1.5.2 Global L-Dopa Sales Quantity (2018-2029)
1.5.3 Global L-Dopa Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Ajinomoto
2.1.1 Ajinomoto Details
2.1.2 Ajinomoto Major Business
2.1.3 Ajinomoto L-Dopa Product and Services
2.1.4 Ajinomoto L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Ajinomoto Recent Developments/Updates
2.2 Daiichi Sankyo
2.2.1 Daiichi Sankyo Details
2.2.2 Daiichi Sankyo Major Business
2.2.3 Daiichi Sankyo L-Dopa Product and Services
2.2.4 Daiichi Sankyo L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Daiichi Sankyo Recent Developments/Updates
2.3 Divis Laboratories
2.3.1 Divis Laboratories Details
2.3.2 Divis Laboratories Major Business
2.3.3 Divis Laboratories L-Dopa Product and Services
2.3.4 Divis Laboratories L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Divis Laboratories Recent Developments/Updates
2.4 Tiefenbacher API + Ingredients
2.4.1 Tiefenbacher API + Ingredients Details
2.4.2 Tiefenbacher API + Ingredients Major Business
2.4.3 Tiefenbacher API + Ingredients L-Dopa Product and Services
2.4.4 Tiefenbacher API + Ingredients L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tiefenbacher API + Ingredients Recent Developments/Updates
2.5 Teva Pharmaceutical Industries
2.5.1 Teva Pharmaceutical Industries Details
2.5.2 Teva Pharmaceutical Industries Major Business
2.5.3 Teva Pharmaceutical Industries L-Dopa Product and Services
2.5.4 Teva Pharmaceutical Industries L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.6 Xinhua Pharmaceutical
2.6.1 Xinhua Pharmaceutical Details
2.6.2 Xinhua Pharmaceutical Major Business
2.6.3 Xinhua Pharmaceutical L-Dopa Product and Services
2.6.4 Xinhua Pharmaceutical L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Xinhua Pharmaceutical Recent Developments/Updates
2.7 Zhejiang Huahai Pharmaceutical
2.7.1 Zhejiang Huahai Pharmaceutical Details
2.7.2 Zhejiang Huahai Pharmaceutical Major Business
2.7.3 Zhejiang Huahai Pharmaceutical L-Dopa Product and Services
2.7.4 Zhejiang Huahai Pharmaceutical L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
2.8 Zhejiang Wild Wind Pharmaceutical
2.8.1 Zhejiang Wild Wind Pharmaceutical Details
2.8.2 Zhejiang Wild Wind Pharmaceutical Major Business
2.8.3 Zhejiang Wild Wind Pharmaceutical L-Dopa Product and Services
2.8.4 Zhejiang Wild Wind Pharmaceutical L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
2.9 JL Pharm
2.9.1 JL Pharm Details
2.9.2 JL Pharm Major Business
2.9.3 JL Pharm L-Dopa Product and Services
2.9.4 JL Pharm L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 JL Pharm Recent Developments/Updates
2.10 ChenLv Herb
2.10.1 ChenLv Herb Details
2.10.2 ChenLv Herb Major Business
2.10.3 ChenLv Herb L-Dopa Product and Services
2.10.4 ChenLv Herb L-Dopa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ChenLv Herb Recent Developments/Updates

3 Competitive Environment: L-Dopa by Manufacturer
3.1 Global L-Dopa Sales Quantity by Manufacturer (2018-2023)
3.2 Global L-Dopa Revenue by Manufacturer (2018-2023)
3.3 Global L-Dopa Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of L-Dopa by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 L-Dopa Manufacturer Market Share in 2022
3.4.2 Top 6 L-Dopa Manufacturer Market Share in 2022
3.5 L-Dopa Market: Overall Company Footprint Analysis
3.5.1 L-Dopa Market: Region Footprint
3.5.2 L-Dopa Market: Company Product Type Footprint
3.5.3 L-Dopa Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global L-Dopa Market Size by Region
4.1.1 Global L-Dopa Sales Quantity by Region (2018-2029)
4.1.2 Global L-Dopa Consumption Value by Region (2018-2029)
4.1.3 Global L-Dopa Average Price by Region (2018-2029)
4.2 North America L-Dopa Consumption Value (2018-2029)
4.3 Europe L-Dopa Consumption Value (2018-2029)
4.4 Asia-Pacific L-Dopa Consumption Value (2018-2029)
4.5 South America L-Dopa Consumption Value (2018-2029)
4.6 Middle East and Africa L-Dopa Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global L-Dopa Sales Quantity by Type (2018-2029)
5.2 Global L-Dopa Consumption Value by Type (2018-2029)
5.3 Global L-Dopa Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global L-Dopa Sales Quantity by Application (2018-2029)
6.2 Global L-Dopa Consumption Value by Application (2018-2029)
6.3 Global L-Dopa Average Price by Application (2018-2029)

7 North America
7.1 North America L-Dopa Sales Quantity by Type (2018-2029)
7.2 North America L-Dopa Sales Quantity by Application (2018-2029)
7.3 North America L-Dopa Market Size by Country
7.3.1 North America L-Dopa Sales Quantity by Country (2018-2029)
7.3.2 North America L-Dopa Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe L-Dopa Sales Quantity by Type (2018-2029)
8.2 Europe L-Dopa Sales Quantity by Application (2018-2029)
8.3 Europe L-Dopa Market Size by Country
8.3.1 Europe L-Dopa Sales Quantity by Country (2018-2029)
8.3.2 Europe L-Dopa Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific L-Dopa Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific L-Dopa Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific L-Dopa Market Size by Region
9.3.1 Asia-Pacific L-Dopa Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific L-Dopa Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America L-Dopa Sales Quantity by Type (2018-2029)
10.2 South America L-Dopa Sales Quantity by Application (2018-2029)
10.3 South America L-Dopa Market Size by Country
10.3.1 South America L-Dopa Sales Quantity by Country (2018-2029)
10.3.2 South America L-Dopa Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa L-Dopa Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa L-Dopa Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa L-Dopa Market Size by Country
11.3.1 Middle East & Africa L-Dopa Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa L-Dopa Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 L-Dopa Market Drivers
12.2 L-Dopa Market Restraints
12.3 L-Dopa Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of L-Dopa and Key Manufacturers
13.2 Manufacturing Costs Percentage of L-Dopa
13.3 L-Dopa Production Process
13.4 L-Dopa Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 L-Dopa Typical Distributors
14.3 L-Dopa Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global L-Dopa Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global L-Dopa Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Ajinomoto Basic Information, Manufacturing Base and Competitors
Table 4. Ajinomoto Major Business
Table 5. Ajinomoto L-Dopa Product and Services
Table 6. Ajinomoto L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Ajinomoto Recent Developments/Updates
Table 8. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 9. Daiichi Sankyo Major Business
Table 10. Daiichi Sankyo L-Dopa Product and Services
Table 11. Daiichi Sankyo L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Daiichi Sankyo Recent Developments/Updates
Table 13. Divis Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Divis Laboratories Major Business
Table 15. Divis Laboratories L-Dopa Product and Services
Table 16. Divis Laboratories L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Divis Laboratories Recent Developments/Updates
Table 18. Tiefenbacher API + Ingredients Basic Information, Manufacturing Base and Competitors
Table 19. Tiefenbacher API + Ingredients Major Business
Table 20. Tiefenbacher API + Ingredients L-Dopa Product and Services
Table 21. Tiefenbacher API + Ingredients L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tiefenbacher API + Ingredients Recent Developments/Updates
Table 23. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Major Business
Table 25. Teva Pharmaceutical Industries L-Dopa Product and Services
Table 26. Teva Pharmaceutical Industries L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teva Pharmaceutical Industries Recent Developments/Updates
Table 28. Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Xinhua Pharmaceutical Major Business
Table 30. Xinhua Pharmaceutical L-Dopa Product and Services
Table 31. Xinhua Pharmaceutical L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Xinhua Pharmaceutical Recent Developments/Updates
Table 33. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Zhejiang Huahai Pharmaceutical Major Business
Table 35. Zhejiang Huahai Pharmaceutical L-Dopa Product and Services
Table 36. Zhejiang Huahai Pharmaceutical L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 38. Zhejiang Wild Wind Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Zhejiang Wild Wind Pharmaceutical Major Business
Table 40. Zhejiang Wild Wind Pharmaceutical L-Dopa Product and Services
Table 41. Zhejiang Wild Wind Pharmaceutical L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
Table 43. JL Pharm Basic Information, Manufacturing Base and Competitors
Table 44. JL Pharm Major Business
Table 45. JL Pharm L-Dopa Product and Services
Table 46. JL Pharm L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. JL Pharm Recent Developments/Updates
Table 48. ChenLv Herb Basic Information, Manufacturing Base and Competitors
Table 49. ChenLv Herb Major Business
Table 50. ChenLv Herb L-Dopa Product and Services
Table 51. ChenLv Herb L-Dopa Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. ChenLv Herb Recent Developments/Updates
Table 53. Global L-Dopa Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 54. Global L-Dopa Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global L-Dopa Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 56. Market Position of Manufacturers in L-Dopa, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and L-Dopa Production Site of Key Manufacturer
Table 58. L-Dopa Market: Company Product Type Footprint
Table 59. L-Dopa Market: Company Product Application Footprint
Table 60. L-Dopa New Market Entrants and Barriers to Market Entry
Table 61. L-Dopa Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global L-Dopa Sales Quantity by Region (2018-2023) & (Tons)
Table 63. Global L-Dopa Sales Quantity by Region (2024-2029) & (Tons)
Table 64. Global L-Dopa Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global L-Dopa Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global L-Dopa Average Price by Region (2018-2023) & (US$/Ton)
Table 67. Global L-Dopa Average Price by Region (2024-2029) & (US$/Ton)
Table 68. Global L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 69. Global L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 70. Global L-Dopa Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global L-Dopa Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global L-Dopa Average Price by Type (2018-2023) & (US$/Ton)
Table 73. Global L-Dopa Average Price by Type (2024-2029) & (US$/Ton)
Table 74. Global L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 75. Global L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 76. Global L-Dopa Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global L-Dopa Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global L-Dopa Average Price by Application (2018-2023) & (US$/Ton)
Table 79. Global L-Dopa Average Price by Application (2024-2029) & (US$/Ton)
Table 80. North America L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 81. North America L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 82. North America L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 83. North America L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 84. North America L-Dopa Sales Quantity by Country (2018-2023) & (Tons)
Table 85. North America L-Dopa Sales Quantity by Country (2024-2029) & (Tons)
Table 86. North America L-Dopa Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America L-Dopa Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 89. Europe L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 90. Europe L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 91. Europe L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 92. Europe L-Dopa Sales Quantity by Country (2018-2023) & (Tons)
Table 93. Europe L-Dopa Sales Quantity by Country (2024-2029) & (Tons)
Table 94. Europe L-Dopa Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe L-Dopa Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 97. Asia-Pacific L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 98. Asia-Pacific L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 99. Asia-Pacific L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 100. Asia-Pacific L-Dopa Sales Quantity by Region (2018-2023) & (Tons)
Table 101. Asia-Pacific L-Dopa Sales Quantity by Region (2024-2029) & (Tons)
Table 102. Asia-Pacific L-Dopa Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific L-Dopa Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 105. South America L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 106. South America L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 107. South America L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 108. South America L-Dopa Sales Quantity by Country (2018-2023) & (Tons)
Table 109. South America L-Dopa Sales Quantity by Country (2024-2029) & (Tons)
Table 110. South America L-Dopa Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America L-Dopa Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa L-Dopa Sales Quantity by Type (2018-2023) & (Tons)
Table 113. Middle East & Africa L-Dopa Sales Quantity by Type (2024-2029) & (Tons)
Table 114. Middle East & Africa L-Dopa Sales Quantity by Application (2018-2023) & (Tons)
Table 115. Middle East & Africa L-Dopa Sales Quantity by Application (2024-2029) & (Tons)
Table 116. Middle East & Africa L-Dopa Sales Quantity by Region (2018-2023) & (Tons)
Table 117. Middle East & Africa L-Dopa Sales Quantity by Region (2024-2029) & (Tons)
Table 118. Middle East & Africa L-Dopa Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa L-Dopa Consumption Value by Region (2024-2029) & (USD Million)
Table 120. L-Dopa Raw Material
Table 121. Key Manufacturers of L-Dopa Raw Materials
Table 122. L-Dopa Typical Distributors
Table 123. L-Dopa Typical Customers
List of Figures
Figure 1. L-Dopa Picture
Figure 2. Global L-Dopa Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global L-Dopa Consumption Value Market Share by Type in 2022
Figure 4. Purity: 98% Examples
Figure 5. Purity: 99% Examples
Figure 6. Global L-Dopa Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global L-Dopa Consumption Value Market Share by Application in 2022
Figure 8. Parkinson Disease Medicine Examples
Figure 9. Hepatic Encephalopathy Medicine Examples
Figure 10. Others Examples
Figure 11. Global L-Dopa Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global L-Dopa Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global L-Dopa Sales Quantity (2018-2029) & (Tons)
Figure 14. Global L-Dopa Average Price (2018-2029) & (US$/Ton)
Figure 15. Global L-Dopa Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global L-Dopa Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of L-Dopa by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 L-Dopa Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 L-Dopa Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global L-Dopa Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global L-Dopa Consumption Value Market Share by Region (2018-2029)
Figure 22. North America L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 25. South America L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa L-Dopa Consumption Value (2018-2029) & (USD Million)
Figure 27. Global L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global L-Dopa Consumption Value Market Share by Type (2018-2029)
Figure 29. Global L-Dopa Average Price by Type (2018-2029) & (US$/Ton)
Figure 30. Global L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global L-Dopa Consumption Value Market Share by Application (2018-2029)
Figure 32. Global L-Dopa Average Price by Application (2018-2029) & (US$/Ton)
Figure 33. North America L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America L-Dopa Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America L-Dopa Consumption Value Market Share by Country (2018-2029)
Figure 37. United States L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe L-Dopa Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe L-Dopa Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific L-Dopa Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific L-Dopa Consumption Value Market Share by Region (2018-2029)
Figure 53. China L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America L-Dopa Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America L-Dopa Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa L-Dopa Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa L-Dopa Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa L-Dopa Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa L-Dopa Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa L-Dopa Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. L-Dopa Market Drivers
Figure 74. L-Dopa Market Restraints
Figure 75. L-Dopa Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of L-Dopa in 2022
Figure 78. Manufacturing Process Analysis of L-Dopa
Figure 79. L-Dopa Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Ajinomoto
Daiichi Sankyo
Divis Laboratories
Tiefenbacher API + Ingredients
Teva Pharmaceutical Industries
Xinhua Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Wild Wind Pharmaceutical
JL Pharm
ChenLv Herb
jiaGou

Add To Cart

gouMai

Buy Now